First-line treatment of patients with disseminated poorly differentiated neuroendocrine carcinomas with carboplatin, etoposide, and vincristine: a single institution experience

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

  • Ingrid Holst Olsen
  • Seppo W Langer
  • Ida Jepsen
  • Maria Assens
  • Birgitte Federspiel
  • Jane Preuss Hasselby
  • Carsten Palnaes Hansen
  • Kjær, Andreas
  • Knigge, Ulrich
Poorly differentiated neuroendocrine carcinomas (PDECs) represent highly malignant tumors with an immense tendency to metastasize and with a poor prognosis. The treatment consists of palliative chemotherapy and corresponds to the treatment of extensive stage small cell lung cancer.
OriginalsprogEngelsk
TidsskriftActa Oncologica
Vol/bind51
Udgave nummer1
Sider (fra-til)97-100
Antal sider4
ISSN0284-186X
DOI
StatusUdgivet - 2012

ID: 40171608